An international collaboration to standardize HIV-2 viral load assays: Results from the 2009 ACHI EV 2E quality control study

Journal of Clinical Microbiology

Volumn 49, Issue 10, 2011, Pages 3491-3497

  Damond, F ^a   Benard, A ^b   Balotta, Claudia ^c   Böni, Jürg ^d   Cotten, Matthew ^e   Duque, Vitor ^f   Ferns, Bridget ^g   Garson, Jeremy ^g   Gomes, Perpetua ^h,i   Gonçalves, Fátima ^h   Gottlieb, Geoffrey ^j   Kupfer, Bernd ^k   Ruelle, Jean ^l   Rodes, Berta ^m   Soriano, Vicente ^m   Wainberg, Mark ⁿ   Taieb, Audrey ^b   Matheron, Sophie ^a,o   Chene, Genevieve ^b   Brun Vezinet, Francoise ^a,o  

^a BICHAT HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^f CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^g ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^h HOSPITAL EGAS MONIZ   (Portugal)

ⁱ INSTITUTO SUPERIOR DE CIÊNCIAS DA SAÚDE EGAS MONIZ   (Portugal)

^j UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF BONN   (Germany)

^l UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^m HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

ⁿ MCGILL UNIVERSITY   (Canada)

^o UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; CONTROLLED STUDY; GOOD LABORATORY PRACTICE; HIV 2 VIRUS LOAD ASSAY; HIV TEST; HUMAN IMMUNODEFICIENCY VIRUS 2; INTERMETHOD COMPARISON; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RNA ANALYSIS; STANDARDIZATION; VALIDATION PROCESS; VIRUS ISOLATION; VIRUS LOAD; VIRUS STRAIN;

HIV INFECTIONS; HIV-2; HUMANS; INTERNATIONAL COOPERATION; OBSERVER VARIATION; PLASMA; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 80053517804     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02389-10     Document Type: Article

References (32)

1. Arien, K. K., et al. 2005. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. J. Virol. 79:8979-8990. (Pubitemid 40934809)
2. Benard, A., et al. 2011. Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: the ACHIEV2E Collaboration Study Group. Clin. Infect. Dis. 52:1257-1266.
3. Borget, M. Y., K. Diallo, C. Adje-Toure, T. Chorba, and J. N. Nkengasong. 2009. Virologic and immunologic responses to antiretroviral therapy among HIV-1 and HIV-2 dually infected patients: case reports from Abidjan, Cote d'Ivoire. J. Clin. Virol. 45:72-75.
4. Chen, Z., et al. 1997. Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys. J. Virol. 71:3953-3960. (Pubitemid 27172410)
5. Damond, F., C. Apetrei, D. Descamps, F. Brun-Vezinet, and F. Simon. 1999. HIV-1 subtypes and plasma RNA quantification. AIDS 13:286-288. (Pubitemid 29050423)
6. Damond, F., et al. 2001. Variability of human immunodeficiency virus type 2 (HIV-2) infecting patients living in France. Virology 280:19-30. (Pubitemid 34158048)
7. Damond, F., et al. Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification. J. Clin. Microbiol. 48:1413-1416.
8. Damond, F., et al. 2008. Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: results from an international collaboration on HIV-2 infection in 2006. J. Clin. Microbiol. 46:2088-2091. (Pubitemid 351831850)
9. Damond, F., et al. 2005. Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assay. J. Clin. Microbiol. 43:4234-4236. (Pubitemid 41129736)
10. Damond, F., et al. 2007. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR version 1.5 and the Roche COBAS AmpliPrep/COBAS Taq- Man HIV-1 assays. J. Clin. Microbiol. 45:3436-3438. (Pubitemid 47585682)
11. Ferns, R. B., and J. A. Garson. 2006. Development and evaluation of a real-time RT-PCR assay for quantification of cell-free human immunodeficiency virus type 2 using a brome mosaic virus internal control. J. Virol. Methods 135:102-108. (Pubitemid 43728849)
12. Fultz, P. N., et al. 1988. Seroprevalence of HIV-1 and HIV-2 in Guinea Bissau in 1980. AIDS 2:129-132.
13. Gao, F. 2005. Detection of HIV-2 by PCR. Methods Mol. Biol. 304:191-200.
14. Gao, F., et al. 1994. Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J. Virol. 68:7433-7447. (Pubitemid 24328799)
15. Gao, F., L. Yue, P. M. Sharp, and B. H. Hahn. 1993. Genetic typing of HIV-2 from a Senegalese/German heterosexual transmission. AIDS Res. Hum. Retroviruses 9:703-704. (Pubitemid 23231135)
16. Gottlieb, G. S., et al. 2009. Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resource-limited West Africa. Clin. Infect. Dis. 48:476-483.
17. Gottlieb, G. S., et al. 2008. A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa. AIDS 22:2069-2072.
18. Heredia, A., et al. 1998. Phylogenetic analysis of HIV type 2 strains from Portugal. AIDS Res. Hum. Retroviruses 14:471-473. (Pubitemid 28169399)
19. Jallow, S., et al. 2009. Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants. J. Clin. Microbiol. 47:2200-2208.
20. Matheron, S., et al. 2003. Factors associated with clinical progression in HIV-2-infected patients: the French ANRS cohort. AIDS 17:2593-2601. (Pubitemid 38402337)
21. Muyldermans, G., et al. 2000. Blinded, multicenter quality control study for the quantification of human immunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories. Clin. Microbiol. Infect. 6:213-217. (Pubitemid 34966055)
22. Naucler, A., P. A. Andreasson, C. M. Costa, R. Thorstensson, and G. Biberfeld. 1989. HIV-2-associated AIDS and HIV-2 seroprevalence in Bissau, Guinea-Bissau. J. Acquir. Immune Defic. Syndr. 2:88-93. (Pubitemid 19127081)
23. Ntemgwa, M. L., et al. 2009. Nucleoside and nucleotide analogs select in culture for different patterns of drug resistance in human immunodeficiency virus types 1 and 2. Antimicrob. Agents Chemother. 53:708-715.
24. Rodes, B., et al. 2007. Quantitative detection of plasma human immunodeficiency virus type 2 subtype A RNA by the Nuclisens EasyQ Assay (version 1.1). J. Clin. Microbiol. 45:88-92. (Pubitemid 46106411)
25. Ruelle, J., B. K. Mukadi, M. Schutten, and P. Goubau. 2004. Quantitative real-time PCR on LightCycler for the detection of human immunodeficiency virus type 2 (HIV-2). J. Virol. Methods 117:67-74. (Pubitemid 38281286)
26. Sarfo, F. S., et al. 2009. Inadvertent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in dual HIV-1/2 and HIV-2 seropositive West Africans: a retrospective study. J. Antimicrob. Chemother. 64:667-669.
27. Scott, L. E., et al. 2009. Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 assays. J. Clin. Microbiol. 47:2209-2217.
28. Smallman-Raynor, M., and A. Cliff. 1991. The spread of human immunodeficiency virus type 2 into Europe: a geographical analysis. Int. J. Epidemiol. 20:480-489.
29. Soriano, V., et al. 2000. Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load. J. Med. Virol. 61:111-116. (Pubitemid 30191235)
30. Toro, C., et al. 2002. Infection with retroviruses other than HIV-1 in Spain: a retrospective analysis for HIV-2, HTLV-I, and/or HTLV-II. HIV Clin. Trials 3:397-402.
31. Valadas, E., L. Franca, S. Sousa, and F. Antunes. 2009. 20 years of HIV-2 infection in Portugal: trends and changes in epidemiology. Clin. Infect. Dis. 48:1166-1167.
32. Wirden, M., et al. 2009. Impact of discrepancies between the Abbott Real- Time and Cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes. J. Clin. Microbiol. 47:1543-1545.